Page 6 - Final Slides

Learning objectives

After completion of this program, participants will be able to:

1. Recognize early RCC disease stage symptoms and underlying risk

factors associated with recurrence rates

2. Assess emergent adjuvant RCC clinical trial data and their impact on

current clinical practice

3. Identify key patient factors important for the consideration of

adjuvant therapy in early stage RCC

8
RCC: renal cell carcinoma.